QLS
Curated by SignalDeveloper of an AI-enabled platform for the clinical analysis of drug molecule
Overview
Developer of an AI-enabled platform for the clinical analysis of drug molecule. The company uses machine learning to predict clinical trial outcomes of a drug molecule. The company's product portfolio includes Predictive Analytics and Portfolio Management.
Key facts
- Founded
- 2019
- Headquarters
- Cambridge, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Contact
- Sign up to view